XL-388
XL-388 is a highly potent and ATP-competitive inhibitor of mTOR (mammalian target of rapamycin), a serine/threonine protein kinase that regulates cell growth, cell proliferation, cell motility, cell survival, protein synthesis, and transcription.
Mechanism of Action[edit | edit source]
XL-388 works by inhibiting the mTOR pathway, which is often overactive in many types of cancer. This inhibition prevents the growth and proliferation of cancer cells. The mTOR pathway is a key regulator of cell growth and proliferation, and its inhibition is a promising strategy for cancer treatment.
Pharmacokinetics[edit | edit source]
The pharmacokinetics of XL-388 are not fully understood. However, it is known that it is highly potent and ATP-competitive, meaning it competes with ATP for binding to the mTOR kinase. This competition inhibits the activity of mTOR, preventing the growth and proliferation of cancer cells.
Clinical Trials[edit | edit source]
XL-388 has been tested in preclinical trials for its potential use in treating various types of cancer. These trials have shown promising results, with XL-388 demonstrating significant anti-tumor activity. However, further research and clinical trials are needed to fully understand the potential of XL-388 as a cancer treatment.
Side Effects[edit | edit source]
As with any drug, XL-388 may have potential side effects. These can include nausea, vomiting, diarrhea, and fatigue. However, these side effects are generally mild and manageable. More serious side effects can include liver damage and blood clotting disorders. Patients should be monitored closely for these potential side effects during treatment with XL-388.
Future Research[edit | edit source]
Future research on XL-388 will focus on further understanding its mechanism of action, pharmacokinetics, and potential side effects. Additionally, more clinical trials are needed to determine the efficacy of XL-388 in treating various types of cancer.
See Also[edit | edit source]
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
